|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Skin Ulcer | |||||
| Diabetic Neuropathies | |||||
| Diabetic Foot | |||||
| Foot Ulcer | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Ulcer | |||||
| 3 | More general conditions related to this trial | ||||
| Cardiovascular Diseases | |||||
| Diabetes Complications | |||||
| Diabetes Mellitus | |||||
| Diabetic Angiopathies | |||||
| Endocrine System Diseases | |||||
| Foot Diseases | |||||
| Leg Ulcer | |||||
| Nervous System Diseases | |||||
| Neuromuscular Diseases | |||||
| Pathologic Processes | |||||
| Peripheral Nervous System Diseases | |||||
| Skin Diseases | |||||
| Vascular Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Becaplermin | |||||
| 5 | Sponsors listed in this trial | ||||
| Johnson &Johnson Pharmaceutical Research &Development, L.L.C. | |||||